Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-08-17

Clinical Trial Update: Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing duloxetine vs imipramine in women with stress urinary incontinence was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)
  • Imipramine (imipramine)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Stress Urinary Incontinence | Phase 3 | Status: WITHDRAWN